Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Net Income | -195.58% | 72.94% | -65.39% | -798.90% | -0.65% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -183.90% | -- | -- | 15,669.44% | -- |
| Change in Net Operating Assets | -50.93% | -3.79% | 326.60% | -13.63% | 300.34% |
| Cash from Operations | -1,465.35% | 58.38% | -50.31% | -125.77% | 85.29% |
| Capital Expenditure | -- | -- | -- | 189.34% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.08% | 107.56% | -5,476.47% | -5,817.86% | -928.00% |
| Cash from Investing | 85.08% | 106.32% | 66.81% | 62.24% | 30.60% |
| Total Debt Issued | -- | -103.26% | -98.95% | 5,321.12% | -0.46% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -76.81% | -80.58% | 246.34% | -- | 148.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 287.32% | -72.23% | -890.63% | -59.26% | -4,413.79% |
| Cash from Financing | 173.90% | -75.10% | -13.13% | 20.18% | 9.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.55% | -400.00% | -133.33% | -22.11% | 116.92% |
